BlackRock, Inc. 13D and 13G filings for Axsome Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-26 5:25 pm Purchase | 2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | BlackRock Inc. BLK | 3,239,746 6.800% | 736,769 (+29.44%) | Filing |
| 2023-02-01 4:54 pm Purchase | 2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | BlackRock Inc. BLK | 2,502,977 5.800% | 393,355 (+18.65%) | Filing |
| 2022-02-03 4:41 pm Sale | 2021-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | BlackRock Inc. BLK | 2,109,622 5.600% | -170,144 (-7.46%) | Filing |
| 2021-01-28 5:55 pm Purchase | 2020-12-31 | 13G | Axsome Therapeutics, Inc. AXSM | BlackRock Inc. BLK | 2,279,766 6.100% | 119,520 (+5.53%) | Filing |